Author: Livozo Editorial. Clinical review: TODO(clinical): reviewer profile pending. See reviewer status. Educational content only; not medical advice.
Different pathways
NAD+ participates in cellular metabolism. Sermorelin acts on the growth-hormone axis.
Different questions
Evidence quality, route, monitoring, contraindications, and goals differ. A clinician should not treat them as substitutes.
Current Livozo status
Both are partner-catalog pathways marked coming soon. Neither can be purchased or prescribed on this site today.